Epimune Partners With Leading Clinical and Research Centers
Industry Partners
Research Funding
Funded Projects
EPI-LYMPH
KMU-innovativ-23: EPI-LYMPH - Development of an epigenetic test to support diagnosis, prognosis and
monitoring of malignant B-cell Non-Hodgkin Lymphoma (NHL); TP A
Supported by the German Federal Ministry of Education and Research
e:KID
e:Kid is a collaborative project involving clinical departments, research institutes, biometrics departments, translational, and industrial partners. The aim of e:Kid is creating and validating a systems medicine based model allowing personalized therapy at early stage after kidney transplantation. Epimune's activities aim at the discovery and development of epigenetic biomarkers for risk assessment, prognosis, and prediction of post transplant course upon kidney transplantation. Supported by the German Federal Ministry of Education and Research (BMBF)